In the afternoon of Mar. 21st, 2019, at invitation Lianzhi took part in the seminars held in Hangzhou High-tech Enterprise Incubation Park by Hangzhou Just Biotherapeutics Inc..

During the seminar, doctor Le Sun of AbMax Beijing, doctors Maohua Li and Xiaoming Yang of Hangzhou Just Biotherapeutics Inc. delivered presentations titled respectively with “AI-powered Antibody Drug Development “, “Biomedical drug immunogenicity and pharmacokinetic method construction”, “CMC Development for large Molecules”. By means of giving comparison, metaphor, and examples, the experts elaborated on the importance of AI techniques in the R & D of antibody drugs, new findings in biomedical immunogenicity, features and future development of pharmacokinetic method construction, status quo of large molecule drug workmanship and product development, making audience feel more optimistic about the bright prospect of the fast-growing biomedical industry.  

During the sideline of the seminar, Lianzhi CEO Mr. Chunliu Yu had an amicable talk with Doctor Mr. Xiaoming Yang, also deputy chairman of Hangzhou Just Biotherapeutics Inc., introducing the advantages of the international pharmaceutical talent headhunting services Lianzhi provides. Indeed, Lianzhi’s operation of supplying foreign pharmaceutical talents is bound to facilitate international cooperation in pharmaceutical industry, helping pharmaceutical companies complement each other to solidify the construction of pharma talent teams in China, broaden China-based companies’ international vision and help internationalize enterprises. Doctor Yang agreed with Lianzhi CEO’s idea, expressing their company’s intention to deepen cooperation with Lianzhi in consolidating the team construction of pharma talents in China.  

About Just Biotherapeutics

Just is a unique platform company that integrates the design, development and manufacture of biologics. With deep experience in the fields of protein, process and manufacturing sciences, the Just team came together to solve the scientific and technical hurdles that block access to life-changing protein therapeutics, from the design of therapeutic molecules to the design of the manufacturing plants used to produce them.  Our focus and passion is to create access and value for a global market through scientific and technological innovation. For more information visit http://just.bio.